TABLE 1.
Inhibitor | k2 | k−2 | t½a | Residence timea | K−1app | Kiapp | koffb | K1c |
---|---|---|---|---|---|---|---|---|
min−1 | min−1 | min | min | nm | nm | min−1 | pm | |
PT70 | 0.46 ± 0.003 | 0.041 ± 0.003e | 17 ± 1 | 24 ± 2 | 62 ± 2 | 7.8 ± 0.4 | 0.043 ± 0.006 | 22 ± 1 |
PT70 | 0.46 ± 0.003 | 0.044 ± 0.008f | 17 ± 1 | 24 ± 2 | 62 ± 2 | 7.8 ± 0.4 | 0.043 ± 0.006 | 22 ± 1 |
INH-NADd | 0.13 ± 0.01 | 0.016 ± 0.007 | 43 ± 12 | 63 ± 27 | 100 ± 75 | 5.0 ± 0.5 | 0.017 ± 0.001 |
a t½ = 0.693/koff and residence time = 1/koff, where koff = k−1k−2/(k−1 + k2 + k−2). Assuming that k−1 ≪ k2 and k−2, then koff ≈ k−2.
b koff was determined by monitoring the rate of release of 32P-NAD+ from the ternary enzyme·inhibitor complex.
c K1 was determined from preincubation experiments.
d The data were taken from Ref. 5.
e k−2 was determined by progress curve of enzyme·inhibitor complex formation.
f k−2 was determined by progress curve of enzyme activity recovery.